Journal of the American Academy of Dermatology
Volume 63, Issue 2 , Pages 292-308 , August 2010

Cutaneous CD4+ CD56+ hematologic malignancies

  • Cynthia M. Magro, MD

      Affiliations

    • Department of Pathology, Weill Medical College of Cornell University, New York, New York
    • Corresponding Author InformationReprint requests: Cynthia M. Magro, MD, Department of Pathology, Weill Cornell Medical Center, 1300 York Ave, F-309A, New York, NY 10044.
  • ,
  • Pierluigi Porcu, MD

      Affiliations

    • Division of Hematology and Oncology, Ohio State University, Columbus, Ohio
  • ,
  • Jochen Schaefer, MD

      Affiliations

    • Department of Pathology, Weill Medical College of Cornell University, New York, New York
  • ,
  • Jack W. Erter, MD

      Affiliations

    • Division of Hematology and Oncology, Ohio State University, Columbus, Ohio
  • ,
  • Richard R. Furman, MD

      Affiliations

    • Division of Hematology and Oncology, Weill Medical College of Cornell University, New York, New York
  • ,
  • Paul K. Shitabata, MD

      Affiliations

    • Pathology Inc, Torrance, California
  • ,
  • A. Neil Crowson, MD

      Affiliations

    • Regional Medical Laboratories, St John Medical Center, University of Oklahoma, Tulsa, Oklahoma

References 

  1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768–3785
  2. Nava VE, Jaffe ES. The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol. 2005;12:27–34
  3. Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas; definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103–111
  4. Petrella T, Comeau MR, Maynadie M, Couillault G, De Muret A, Maliszewski CR, et al. Agranular CD4+ CD56+ hematodermic neoplasm (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002;26:852–862
  5. Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D. CD56+ TdT+ blastic natural killer cell tumor of the skin. Cancer. 2002;94:2401–2408
  6. Shiman M, Marchione R, Ricotti C, Romanelli P, Alonso-Llamazares J. CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell tumor). Dermatol Online J. 2008;14:5
  7. Kluin PM, Feller A, Gaulard P, Jaffe ES, Meijer CJ, Muller-Hermelink HK, et al. Peripheral T/NK-cell lymphoma: a report of the IXth workshop of the European Association for Hematopathology. Histopathology. 2001;38:250–270
  8. Greer JP, Kinney MC, Loughran TP. T cell and NK cell lymphoproliferative disorders. Hematology Am Soc Hematol Educ Program. 2001;259–281
  9. Hamadani M, Magro CM, Porcu P. CD4+ CD56+ hematodermic tumor (plasmacytoid dendritic cell neoplasm). Br J Haematol. 2008;140:122
  10. Alonsozana EL, Stamberg J, Kumar D, Jaffe ES, Medeiros LJ, Frantz C, et al. Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gamma delta T cell lymphoma. Leukemia. 1997;11:1367–1372
  11. Tamaska J, Adam E, Kozma A, Gopcsa L, Andrikovics H, Tordai A, et al. Hepatosplenic gammadelta T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration. Virchows Arch. 2006;449:479–483
  12. Liu XY, Atkins R, Feusner JH, Rowland JM. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement. Am J Hematol. 2004;57:251–253
  13. Hofbauer GF, Kamarachev J, Kempf W, Burg G, Pestalozzi BC, Dummer R. A CD4+CD56+ natural killer-like T-cell systemic lymphoma with hemorrhagic cutaneous manifestations. Br J Dermatol. 2001;144:414–448
  14. Aoyama Y, Yamane T, Hino M, Ohta K, Nakamae H, Yamamura R, et al. Blastic NK cell lymphoma/leukemia with T-cell receptor-gamma rearrangement. Ann Hematol. 2001;80:752–754
  15. Stetsenko GY, McFarlane R, Kalus A, Olerud J, Cherian S, Fromm J, et al. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement. J Cutan Pathol. 2008;35:579–584
  16. Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK, Jones D. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms. Mod Pathol. 2006;19:1555–1562
  17. Di Pucchio T, Lapenta C, Santini SM, Logozzi M, Parlato S, Belardelli F. CD2+/CD14+ monocytes rapidly differentiate into CD83+ dendritic cells. Eur J Immunol. 2003;33:358–367
  18. Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D. TCL1 expression in plasmocytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood. 2003;101:5007–5009
  19. Ferran M, Gallardo F, Ferrer AM, Salar A, Pérez-Vila E, Juanpere N, et al. Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge. Br J Dermatol. 2008;158(5):
  20. Munoz L, Nomdedeu JF, Lopez O. Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies. Haematologica. 2001;86:1261–1269
  21. Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia. 2000;14:1777–1784
  22. Zhou LJ, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U S A. 1996;93:2588–2592
  23. Welner RS, Pelayo R, Garrett KP, Chen X, Perry SS, Sun XH, et al. Interferon-producing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors. Blood. 2007;109:4825–4931
  24. Novotny JR, Nucke H, Duhrsen U. Correlation between expression of CD56/NCAM and severe leukostasis in hyperleukocytic acutae myelomonocytic leukemia. Eur J Haematol. 2006;76:299–308
  25. Murakami Y, Nagae S, Matsuishi E, Irie K, Furue M. A case of CD56+ cutaneous aleukemic granulocytic sarcoma with myelodysplastic syndrome. Br J Dermatol. 2000;143:587–590
  26. Lacronique-Gazaille C, Chaury MP, Le Guyader A, Faucher JL, Bordessoule D, Feuillard J. A simple method for detection of major phenotypic abnormalities in myelodysplastic syndromes: expression of CD56 in CMML. Haematologica. 2007;92:859–860
  27. Byrd JC, Edenfield WJ, Dow NS, Aylesworth C, Dawson N. Extramedullary myeloid cell tumors in myelodysplastic-syndromes: not a true indication of impending acute myeloid leukemia. Leuk Lymphoma. 1996;21:153–159
  28. Boudova L, Kazakov DV, Jindra P, Sima R, Vanecek T, Kuntscher V, et al. Primary cutaneous histiocyte and neutrophil-rich CD30+ and CD56+ anaplastic large-cell lymphoma with prominent angioinvasion and nerve involvement in the forehead and scalp of an immunocompetent woman. J Cutan Pathol. 2006;33:584–589
  29. Kim HK, Jin SY, Lee NS, Won JH, Park HS, Yang WI. Posttransplant primary cutaneous Ki-1 (CD30)+/CD56+ anaplastic large cell lymphoma. Arch Pathol Lab Med. 2004;128:96–99
  30. Suzuki R, Kagami Y, Takeuchi K, Kami M, Okamoto M, Ichinohasama R, et al. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype. Blood. 2000;96:2993–3000
  31. Paulli M, Boveri E, Rosso R, Aricò M, Kindl S, Viglio A, et al. CD56/neural cell adhesion molecule expression in primary extranodal Ki-1/CD30+ lymphoma: report of a pediatric case with simultaneous cutaneous and bone localizations. Am J Dermatopathol. 1997;19:834–890
  32. Dunphy CH, DeMello DE, Gale GB. Pediatric CD56+ anaplastic large cell lymphoma: a review of the literature. Arch Pathol Lab Med. 2006;130:1859–1864
  33. Krenacs L, Wellmann A, Sorbara L, Himmelmann AW, Bagdi E, Jaffe ES, et al. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood. 1997;89:980–989
  34. Chang SE, Park IJ, Huh J, Choi JH, Sung KJ, Moon KC, et al. CD56 expression in a case of primary cutaneous CD30+ anaplastic large cell lymphoma. Br J Dermatol. 2000;142:766–770
  35. Gould JW, Eppes RB, Gilliam AC, Goldstein JA, Mikkola DL, Zaim MT, et al. Solitary primary cutaneous CD30+ large cell lymphoma of natural killer cell phenotype bearing the t(2;5)(p23;q35) translocation and presenting in a child. Am J Dermatopathol. 2000;22:422–428
  36. Coyne JD, Banerjee SS, Bromley M, Mills S, Diss TC, Harris M. Post transplant T cell lymphoproliferative disorder/T cell lymphoma: a report of three cases of T anaplastic large cell lymphoma with cutaneous presentation and a review of the literature. Histopathology. 2004;44:387–393
  37. Walker P, Long D, James C, Marshman G. Exaggerated insect bite reaction exacerbated by a pyogenic infection in a patient with chronic lymphocytic leukemia. Australas J Dermatol. 2007;48:165–169
  38. Kunitomi A, Konaka Y, Yagita M. Hypersensitivity to mosquito bites as a potential sign of mantle cell lymphoma. Intern Med. 2005;44:1097–1099
  39. Vassallo C, Passamonti F, Cananzi R, Brazzelli V, Ardigò M, Lazzarino M, et al. Exaggerated insect bite-like reaction in patients affected by oncohematological diseases. Acta Derm Venereol. 2005;85:76–77
  40. Barzilai A, Shapiro D, Goldberg I, Yacob-Hirsch Y, Diaz-Cascajo C, Meytes D, et al. Insect bite-like reaction in patients with hematologic malignant neoplasms. Arch Dermatol. 1999;135:1503–1507
  41. Martinez A, Pittaluga S, Villamor N, Colomer D, Rozman M, Raffeld M, et al. Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis. Am J Surg Pathol. 2004;28:849–858
  42. Santucci M, Pimpinelli N, Massi D, Kadin ME, Meijer CJ, Muller-Hermelink HK, et al. Cytotoxic natural killer cell cutaneous lymphomas: report of the EORTC cutaneous lymphoma task force workshop. Cancer. 2003;97:610–627
  43. Klekotka PA, Faulkner-Jones B, Heffernan MP. A case of CD56+ mycosis fungoides. Arch Dermatol. 2006;142:1370–1372
  44. Wain EM, Orchard GE, Mayou S, Atherton DJ, Misch KJ, Russell-Jones R. Mycosis fungoides with a CD56+ immunophenotype. J Am Acad Dermatol. 2005;53:158–163
  45. Ohshima A, Tokura YM, Misawa JM, Yagi HM, Takigawa M. Erythrodermic cutaneous T cell lymphoma with CD8+CD56+ leukemic T cells in a young woman. Br J Dermatol. 2003;149:891–893
  46. Satoh M, Seki S, Hashimoto W, Ogasawara K, Kobayashi T, Kumagai K, et al. Cytotoxic gammadelta or alpha beta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. J Immunol. 1996;157:3886–3892
  47. Taddesse-Heath L, Feldman JI, Fahle GA, Fischer SH, Sorbara L, Raffeld M, et al. Florid CD4+, CD56+ T-cell infiltrate associated with herpes simplex infection simulating nasal NK-/T-cell lymphoma. Mod Pathol. 2003;16:166–172
  48. Eksioglu-Demiralp E, Direskeneli H, Ergun T, Fresko I, Akoglu T. Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behçet's disease. Rheumatol Int. 1999;19:23–26
  49. Vergelli M, Le H, van Noort JM, Dhib-Jalbut S, McFarland H, Martin R. A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule. J Immunol. 1996;157:679–688
  50. Bachetoni A, Lionetti P, Cinti P, Alò P, Molajoni ER, Di Tondo U, et al. Homing of CD4+CD56+ T lymphocytes into kidney allografts during tubular necrosis or rejection. Clin Transplant. 1995;9:433–437
  51. Barnaba V, Franco A, Paroli M, Benvenuto R, De Petrillo G, Burgio VL, et al. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol. 1994;152:3074–3087
  52. Lima M, Almeida J, Dos Anjos Teixeira M, Alguero Md Mdel C, Santos AH, Balanzategui A, et al. TCRαß+/CD4+ large granular lymphocytosis–a new clonal T-cell lymphoproliferative disorder. Am J Pathol. 2003;163:763–771

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(09)01198-0

doi: 10.1016/j.jaad.2009.08.044

Journal of the American Academy of Dermatology
Volume 63, Issue 2 , Pages 292-308 , August 2010